Thu, March 15, 2018
Wed, March 14, 2018
Tue, March 13, 2018
Mon, March 12, 2018
Fri, March 9, 2018
Thu, March 8, 2018
Wed, March 7, 2018
Tue, March 6, 2018
Mon, March 5, 2018
Fri, March 2, 2018
Thu, March 1, 2018
Wed, February 28, 2018
Tue, February 27, 2018
Mon, February 26, 2018
Fri, February 23, 2018

Jason McCarthy Maintained (VRTX) at Strong Buy with Increased Target to $200 on, Mar 5th, 2018


//stocks-investing.news-articles.net/content/201 .. ith-increased-target-to-200-on-mar-5th-2018.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Jason McCarthy of Maxim Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $195 to $200 on, Mar 5th, 2018.

Jason has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 0 agree with Jason's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Jason


  • Alethia Young of "Credit Suisse" Maintained at Buy with Increased Target to $196 on, Tuesday, February 13th, 2018
  • Liisa Bayko of "JMP Securities" Maintained at Buy with Increased Target to $211 on, Tuesday, February 13th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $200 on, Friday, February 2nd, 2018
  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $197 on, Thursday, February 1st, 2018
  • Do Kim of "BMO Capital" Maintained at Buy with Increased Target to $191 on, Thursday, February 1st, 2018
  • Geoff Meacham of "Barclays" Maintained at Buy with Increased Target to $200 on, Thursday, February 1st, 2018

Publication Contributing Sources